vs
Astrana Health, Inc.（ASTH）与Real Brokerage Inc（REAX）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是Real Brokerage Inc的1.7倍（$950.5M vs $568.5M），Astrana Health, Inc.净利率更高（0.7% vs -0.1%，领先0.8%），Real Brokerage Inc同比增速更快（52.6% vs 42.9%），Real Brokerage Inc自由现金流更多（$8.4M vs $-6.0M）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
该企业是美国房产服务企业，主营房产经纪业务运营与品牌特许经营，业务覆盖房产中介、 relocation服务、产权服务、保险及结算服务，旗下拥有Better Homes and Gardens Real Estate、21世纪不动产、Coldwell Banker、Corcoran Group、ERA房地产以及苏富比国际地产等多个知名品牌，2026年被Compass, Inc.收购。
ASTH vs REAX — 直观对比
营收规模更大
ASTH
是对方的1.7倍
$568.5M
营收增速更快
REAX
高出9.7%
42.9%
净利率更高
ASTH
高出0.8%
-0.1%
自由现金流更多
REAX
多$14.4M
$-6.0M
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $568.5M |
| 净利润 | $6.6M | $-447.0K |
| 毛利率 | — | 7.9% |
| 营业利润率 | 1.9% | -0.1% |
| 净利率 | 0.7% | -0.1% |
| 营收同比 | 42.9% | 52.6% |
| 净利润同比 | 184.4% | 82.7% |
| 每股收益（稀释后） | $0.12 | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHREAX
| Q4 25 | $950.5M | — | ||
| Q3 25 | $956.0M | $568.5M | ||
| Q2 25 | $654.8M | $540.7M | ||
| Q1 25 | $620.4M | $354.0M | ||
| Q4 24 | $665.2M | — | ||
| Q3 24 | $478.7M | $372.5M | ||
| Q2 24 | $486.3M | — | ||
| Q1 24 | $404.4M | $200.7M |
净利润ASTHREAX
| Q4 25 | $6.6M | — | ||
| Q3 25 | $373.0K | $-447.0K | ||
| Q2 25 | $9.4M | $1.5M | ||
| Q1 25 | $6.7M | $-5.0M | ||
| Q4 24 | $-7.8M | — | ||
| Q3 24 | $16.1M | $-2.6M | ||
| Q2 24 | $19.2M | — | ||
| Q1 24 | $14.8M | $-16.1M |
毛利率ASTHREAX
| Q4 25 | — | — | ||
| Q3 25 | — | 7.9% | ||
| Q2 25 | — | 8.9% | ||
| Q1 25 | — | 9.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 8.6% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 10.3% |
营业利润率ASTHREAX
| Q4 25 | 1.9% | — | ||
| Q3 25 | 2.0% | -0.1% | ||
| Q2 25 | 3.1% | 0.3% | ||
| Q1 25 | 3.3% | -1.5% | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 5.9% | -0.7% | ||
| Q2 24 | 6.2% | — | ||
| Q1 24 | 7.5% | -7.8% |
净利率ASTHREAX
| Q4 25 | 0.7% | — | ||
| Q3 25 | 0.0% | -0.1% | ||
| Q2 25 | 1.4% | 0.3% | ||
| Q1 25 | 1.1% | -1.4% | ||
| Q4 24 | -1.2% | — | ||
| Q3 24 | 3.4% | -0.7% | ||
| Q2 24 | 3.9% | — | ||
| Q1 24 | 3.7% | -8.0% |
每股收益（稀释后）ASTHREAX
| Q4 25 | $0.12 | — | ||
| Q3 25 | $0.01 | $0.00 | ||
| Q2 25 | $0.19 | $0.01 | ||
| Q1 25 | $0.14 | $-0.02 | ||
| Q4 24 | $-0.14 | — | ||
| Q3 24 | $0.33 | $-0.01 | ||
| Q2 24 | $0.40 | — | ||
| Q1 24 | $0.31 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $38.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | $53.6M |
| 总资产 | $2.2B | $145.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTHREAX
| Q4 25 | $429.5M | — | ||
| Q3 25 | $463.4M | $38.7M | ||
| Q2 25 | $342.1M | $49.7M | ||
| Q1 25 | $260.9M | $24.7M | ||
| Q4 24 | $290.8M | — | ||
| Q3 24 | $350.3M | $22.6M | ||
| Q2 24 | $327.7M | — | ||
| Q1 24 | $337.3M | $20.1M |
股东权益ASTHREAX
| Q4 25 | $779.3M | — | ||
| Q3 25 | $775.5M | $53.6M | ||
| Q2 25 | $765.5M | $49.2M | ||
| Q1 25 | $745.4M | $32.8M | ||
| Q4 24 | $712.7M | — | ||
| Q3 24 | $704.6M | $29.8M | ||
| Q2 24 | $678.9M | — | ||
| Q1 24 | $653.5M | $25.6M |
总资产ASTHREAX
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.2B | $145.2M | ||
| Q2 25 | $1.4B | $149.4M | ||
| Q1 25 | $1.3B | $100.5M | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.3B | $102.5M | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.2B | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $8.8M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $8.4M |
| 自由现金流率自由现金流/营收 | -0.6% | 1.5% |
| 资本支出强度资本支出/营收 | 0.3% | 0.1% |
| 现金转化率经营现金流/净利润 | -0.44× | — |
| 过去12个月自由现金流最近4个季度 | $104.5M | $71.7M |
8季度趋势，按日历期对齐
经营现金流ASTHREAX
| Q4 25 | $-2.9M | — | ||
| Q3 25 | $10.0M | $8.8M | ||
| Q2 25 | $90.9M | $41.0M | ||
| Q1 25 | $16.6M | $15.9M | ||
| Q4 24 | $-10.9M | — | ||
| Q3 24 | $34.0M | $7.2M | ||
| Q2 24 | $23.2M | — | ||
| Q1 24 | $6.0M | $21.5M |
自由现金流ASTHREAX
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $7.4M | $8.4M | ||
| Q2 25 | $89.5M | $40.8M | ||
| Q1 25 | $13.6M | $15.7M | ||
| Q4 24 | $-13.5M | — | ||
| Q3 24 | $31.7M | $6.8M | ||
| Q2 24 | $20.4M | — | ||
| Q1 24 | $5.6M | $21.4M |
自由现金流率ASTHREAX
| Q4 25 | -0.6% | — | ||
| Q3 25 | 0.8% | 1.5% | ||
| Q2 25 | 13.7% | 7.5% | ||
| Q1 25 | 2.2% | 4.4% | ||
| Q4 24 | -2.0% | — | ||
| Q3 24 | 6.6% | 1.8% | ||
| Q2 24 | 4.2% | — | ||
| Q1 24 | 1.4% | 10.7% |
资本支出强度ASTHREAX
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.3% | 0.1% | ||
| Q2 25 | 0.2% | 0.0% | ||
| Q1 25 | 0.5% | 0.1% | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.5% | 0.1% | ||
| Q2 24 | 0.6% | — | ||
| Q1 24 | 0.1% | 0.0% |
现金转化率ASTHREAX
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | — | ||
| Q2 25 | 9.65× | 27.13× | ||
| Q1 25 | 2.48× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 0.40× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
REAX
暂无分部数据
